Sign in

CIK 0001645460 · Non-accelerated filer<br>Smaller reporting company

Cue Biopharma, Inc.

Sign in to watch
Ticker
CUE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473324577
Phone
617-949-2680
Business address
100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
Former names
Imagen Biopharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$389,304
in 3 filings

Net −$389,304. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Lin Shao-Lee −$305K Chief Executive Officer sold 2% of stake
  2. Ray Sumita −$52K Chief Legal Compliance Officer sold 2% of stake
  3. Meluzio Michael Vincent −$32K VP, Prin. Accounting Officer sold 2% of stake

Reading 20 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-08-12 Lin Shao-Lee Chief Executive Officer Option exercise · Common Stock −109,179 218,358
2026-07-30 Ahlers James M Chief Financial Officer Grant or award +25,500 25,500
2026-07-30 Ahlers James M Chief Financial Officer Grant or award · Stock Option (Right to Buy) +51,000 51,000
2026-07-13 Borie Dominique Christian Chief Medical Officer Grant or award +31,500 31,500
2026-07-13 Borie Dominique Christian Chief Medical Officer Grant or award · Stock Option (Right to Buy) +63,000 63,000
2026-07-09 Sarraf Pasha Director Grant or award +18,400 29,195
2026-07-09 Garzone Pamela Director Grant or award +18,900 18,900
2026-07-09 Meluzio Michael Vincent VP, Prin. Accounting Officer Grant or award +40,942 40,942
2026-07-09 Meluzio Michael Vincent VP, Prin. Accounting Officer Grant or award · Common Stock +40,942 40,942
2026-07-09 Meehan Viola Mong Director Grant or award +21,800 21,800
2026-07-09 Sarraf Pasha Director Grant or award +21,800 32,595
2026-07-09 Garzone Pamela Director Grant or award +21,800 21,800
2026-07-09 Camardo Daniel A. Director Grant or award +21,800 21,800
2026-07-09 Lin Shao-Lee Chief Executive Officer Grant or award +327,537 655,074
2026-07-09 Lin Shao-Lee Chief Executive Officer Grant or award · Common Stock +327,537 327,537
2026-07-09 Ray Sumita Chief Legal Compliance Officer Grant or award +54,589 109,178
2026-07-09 Ray Sumita Chief Legal Compliance Officer Grant or award · Common Stock +54,589 54,589
2026-06-01 Lin Shao-Lee Chief Executive Officer Grant or award · Pre-Funded Warrants (Right to Buy) +90,906 $11.00 $1000K 90,906
2026-06-01 Lin Shao-Lee Chief Executive Officer Grant or award · Common Stock Warrants (Right to Buy) +45,453 45,453
2026-06-01 Lin Shao-Lee Chief Executive Officer Purchase · Pre-Funded Warrants (Right to Buy) +90,906 $11.00 $1000K 90,906

Page 2 of 17 · 323 trades